Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)
Condition(s):Sarcoma,Soft Tissue; Gynecologic CancerLast Updated:November 28, 2022Available
Hide Studies Not Open or Pending
Condition(s):Sarcoma,Soft Tissue; Gynecologic CancerLast Updated:November 28, 2022Available
Condition(s):Alveolar Soft Part Sarcoma; Leiomyosarcoma; Synovial Sarcoma; Soft-Tissue SarcomaLast Updated:January 31, 2024Active, not recruiting
Condition(s):Endometrial Carcinoma; Ovarian Carcinoma; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma; Cervical CarcinomaLast Updated:November 8, 2023Active, not recruiting
Condition(s):Endometrial Cancer; Ovarian Cancer; Cervical CancerLast Updated:June 19, 2019Terminated
Condition(s):Solid Tumor, Adult; Soft Tissue Sarcoma; Non Small Cell Lung Cancer; Small Cell Lung CancerLast Updated:May 22, 2023Active, not recruiting
Condition(s):Small Cell Lung CarcinomaLast Updated:February 8, 2024Recruiting
Condition(s):Diet, High-Fat; PharmacokineticsLast Updated:August 3, 2022Recruiting
Condition(s):Small Cell Lung CancerLast Updated:March 12, 2024Recruiting
Condition(s):Small Cell Lung CancerLast Updated:May 18, 2021Unknown status
Condition(s):Advanced Solid TumorsLast Updated:May 18, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.